Bm Bm13 Globule
Product Images NDC 85816-7013

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bm Bm13 (NDC 85816-7013). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bm Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bm13 2 (Bm No 13 2)

Bm13 2 (Bm No 13 2)
The label for BM BM13 13 Drosera compound homoeopathic product lists active ingredients including Belladonna 4X, Cuprum Aceticum 6X, Drosera 3X, Grindelia 4X, Ipecac 5X, Lobelia Inflata 2X, Naphthalinum 12X, and Yerba Santa 4X. The label includes product type, manufacturing details by BM Homoeopathic Pharmaceuticals, market authorization holder information, and indications to read the enclosed package leaflet. The product weight is marked as 500g.*
FDA Label Image

Bm 13 (Bm No 13)

Bm 13 (Bm No 13)
Label of BM BM13 Drosera compound homoeopathic product showing active ingredients Belladonna 4X, Cuprum Aceticum 6X, Drosera 3X, Grindelia 4X, Ipecac 5X, Lobelia Inflata 2X, Naphthalinum 12X, Yerba Santa 4X. The label includes manufacturer BM Homoeopathic Pharmaceuticals in Lahore, Pakistan, and Market Authorization Holder Bestmade Natural Products in Florida, USA. Product weight indicated is 25g.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.